| Literature DB >> 24387712 |
Anna Nützel1, Anne Dahlhaus, Angela Fuchs, Jochen Gensichen, Hans-Helmut König, Steffi Riedel-Heller, Wolfgang Maier, Ingmar Schäfer, Gerhard Schön, Siegfried Weyerer, Birgitt Wiese, Martin Scherer, Hendrik van den Bussche, Horst Bickel.
Abstract
BACKGROUND: With increasing life expectancy the number of people affected by multimorbidity rises. Knowledge of factors associated with health-related quality of life in multimorbid people is scarce. We aimed to identify the factors that are associated with self-rated health (SRH) in aged multimorbid primary care patients.Entities:
Mesh:
Year: 2014 PMID: 24387712 PMCID: PMC3923097 DOI: 10.1186/1471-2296-15-1
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Description of the instruments
| AUDIT-C | Alcohol Use Disorders Identification Test [ |
| Barthel-Index | Measures performance in basic activities of daily living [ |
| BMI | Body-Mass-Index (weight (kg)/height (m2)); |
| VAS of EQ-5D | Visual analogous scale of the EuroQoL-5D (EQ-5D) [ |
| F-SOZU K-14 | Social support questionnaire [ |
| GCPS | Graded chronic pain scale [ |
| GDS | Geriatric Depression Scale [ |
| IADL | Instrumental Activities of Daily Living [ |
| IPAQ-7 | International Physical Activity Questionnaire [ |
| SWE | Self-Efficacy Scale [ |
| 4 DBL | Four-dimensional symptom questionnaire [ |
Prevalence of self-reported diagnoses by gender and for the whole sample
| Hypertension | 2307 (72.3%) | 939 (72.3%) | 1368 (72.3%) | n.s. |
| Joint arthrosis | 2115 (66.4%) | 718 (55.4%) | 1397 (73.9%) | < 0.001 |
| Chronic low back pain | 1975 (62.0%) | 700 (54.1%) | 1275 (67.5%) | < 0.001 |
| Lipid metabolism disorders | 1460 (45.9%) | 617 (47.6%) | 843 (44.7%) | n.s. |
| Chronic ischemic heart disease | 963 (30.3%) | 549 (42.3%) | 414 (22.0%) | < 0.001 |
| Severe vision reduction | 1396 (43.9%) | 515 (39.7%) | 881 (46.8%) | < 0.001 |
| Prostatic hyperplasia | 511 (20.8%) | 511 (39.6%) | -- | -- |
| Diabetes mellitus | 992 (31.2%) | 479 (37.0%) | 513 (27.2%) | < 0.001 |
| Cardiac arrhythmia | 1044 (32.8%) | 451 (34.8%) | 595 (31.5%) | n.s. |
| Neuropathies | 1114 (34.9%) | 426 (32.8%) | 688 (36.4%) | 0.041 |
| Dizziness | 1109 (34.8%) | 381 (29.4%) | 728 (38.5%) | < 0.001 |
| Lower limb varicosis | 1148 (36.0%) | 321 (24.8%) | 827 (43.8%) | < 0.001 |
| Asthma/COPD1 | 696 (21.8%) | 280 (21.6%) | 416 (22.0%) | n.s. |
| Purine/pyrimidine metabolism disorders/Gout | 536 (16.9%) | 269 (20.8%) | 267 (14.2%) | < 0.001 |
| Haemorrhoids | 727 (22.8%) | 246 (19.0%) | 481 (25.5%) | < 0.001 |
| Cerebral ischemia/Chronic stroke | 444 (13.9%) | 225 (17.4%) | 219 (11.6%) | < 0.001 |
| Cardiac insufficiency | 548 (17.2%) | 214 (16.5%) | 334 (17.7%) | n.s. |
| Atherosclerosis/PAOD2 | 347 (10.9%) | 193 (14.9%) | 154 (8.2%) | < 0.001 |
| Thyroid dysfunction | 991 (31.1%) | 192 (14.8%) | 799 (42.3%) | < 0.001 |
| Cancer | 332 (10.4%) | 171 (13.2%) | 161 (8.8%) | < 0.001 |
| Noninflammatory gynaecological problems | 246 (9.1%) | -- | 246 (13.1%) | -- |
| Renal insufficiency | 307 (9.6%) | 150 (11.6%) | 157 (8.3%) | 0.003 |
| Cardiac valve disorders | 314 (9.9%) | 139 (10.7%) | 175 (9.3%) | n.s. |
| Intestinal diverticulosis | 435 (13.7%) | 138 (10.6%) | 297 (15.7%) | < 0.001 |
| Psoriasis | 213 (6.7%) | 117 (9.0%) | 96 (5.1%) | < 0.001 |
| Rheumatoid arthritis/Chronic polyarthritis | 410 (12.9%) | 112 (8.7%) | 298 (15.8%) | < 0.001 |
| Osteoporosis | 690 (21.7%) | 97 (7.5%) | 593 (31.4%) | < 0.001 |
| Chronic cholecystitis/Gallstones | 271 (8.5%) | 78 (6.0%) | 193 (10.2%) | < 0.001 |
| Urinary tract stones | 124 (3.9%) | 63 (4.9%) | 61 (3.2%) | 0.025 |
| Anemia | 169 (5.3%) | 54 (4.2%) | 115 (6.1%) | 0.019 |
| Migraine/chronic headache | 166 (5.2%) | 37 (2.9%) | 129 (6.8%) | < 0.001 |
| Parkinson’s disease | 67 (2.1%) | 36 (2.8%) | 31 (1.6%) | 0.032 |
Note: 1: chronic obstructive pulmonary disease; 2: peripheral arterial occlusive disease;
3: χ2-test, df = 1, two-sided p, n.s. = not significant (p > 0.05).
Characteristics of the study population
| Self-rated health (SRH) (Mean (SD)) | 62.4 (18.2) | 63.6 (18.4) | 61.6 (18.0) | 0.003 | |
| | | | | | |
| Age, in years (Mean (SD)) | 74.4 (5.2) | 74.0 (5.1) | 74.7 (5.3) | 0.001 | |
| Marital status (N (%)) | | | | | |
| | 1863 (58.4%) | 1026 (79.0) | 837 (44.3) | | |
| | 188 (5.9%) | 56 (4.3) | 132 (7.0) | | |
| | 256 (8.0%) | 74 (5.7) | 182 (9.6) | | |
| | 882 (27.7%) | 142 (10.9) | 740 (39.1) | < 0.001 | (df = 3) |
| Living conditions (N (%)) | | | | | |
| | 1128 (35.4%) | 229 (17.6) | 899 (47.5) | | |
| | 1847 (57.9%) | 1021 (78.7) | 826 (43.7) | | |
| | 214 (6.7%) | 48 (3.7) | 166 (8.8) | < 0.001 | (df = 2) |
| Education (N (%)) | | | | | |
| | 1986 (62.3%) | 753 (58.0) | 1233 (65.2) | | |
| | 856 (26.8%) | 306 (23.6) | 550 (29.1) | | |
| | 347 (10.9%) | 239 (18.4) | 108 (5.7) | < 0.001 | (df = 2) |
| Monthly income (in Euro) (Mean (SD)) | 1412.2 (705.9) | 1517.0 (833.0) | 1340.3 (593.0) | < 0.001 | |
| | | | | | |
| Smoking behavior (N (%)) | | | | ||
| | 292 (9.2%) | 153 (11.8) | 139 (7.3) | | |
| | 1361 (42.7%) | 819 (63.1) | 542 (28.7) | | |
| | 1532 (48.0%) | 324 (25.0) | 1208 (63.9) | < 0.001 | (df = 2) |
| Body mass index (Mean (SD)) | 28.2 (4.9) | 28.1 (4.0) | 28.3 (5.4) | n.s. | |
| Alcohol habits score (Mean (SD)) | 2.2 (1.9) | 3.0 (2.2) | 1.6 (1.5) | < 0.001 | |
| Physical activity (in 1000 MET minutes/week) (Mean (SD)) | 2.2 (2.5) | 2.6 (2.8) | 1.9 (2.2) | < 0.001 | |
| | | | | | |
| Self-efficacy (SWE) (Mean (SD)) | 3.3 (0.6) | 3.4 (0.5) | 3.2 (0.6) | < 0.001 | |
| Social support (F-SOZU) (Mean (SD)) | 4.1 (0.7) | 4.1 (0.7) | 4.1 (0.7) | n.s. | |
| Depression (GDS) (Mean (SD)) | 2.6 (2.6) | 2.3 (2.5) | 2.8 (2.7) | < 0.001 | |
| Somatization (4DBL) (Mean (SD)) | 7.0 (5.1) | 5.7 (4.7) | 7.8 (5.2) | < 0.001 | |
| Anxiety (4DBL) (Mean (SD)) | 1.0 (2.2) | 0.6 (1.7) | 1.3 (2.4) | < 0.001 | |
| Depression (4DBL) (Mean (SD)) | 0.8 (2.0) | 0.7 (1.8) | 1.0 (2.1) | < 0.001 | |
| Distress (4DBL) (Mean (SD)) | 5.9 (5.3) | 4.7 (4.7) | 6.8 (5.5) | < 0.001 | |
| | | | | | |
| Characteristic pain intensity (GCPS) (Mean (SD)) | 34.5 (25.5) | 28.1 (24.7) | 39.0 (25.2) | < 0.001 | |
| Disability score (GCPS) (Mean (SD)) | 26.0 (29.2) | 20.2 (27.3) | 30.0 (29.2) | < 0.001 | |
1: Living with others: including living together with other family members or other persons and living in assisted living or in retirement home; 2 χ2-test or t-test as appropriate, two-sided p, n.s. = not significant (p > 0.05), df: degrees of freedom.
Self-rated health of the whole sample in relation to demographic variables and self-reported diseases
| Hypertension | 61.7 (2307) | 18.0 | 64.3 (882) | 18.5 | <0.001 | 0.14 |
| Joint arthrosis | 60.0 (2115) | 17.9 | 67.2 (1072) | 17.8 | <0.001 | 0.40 |
| Chronic low back pain | 59.1 (1975) | 18.2 | 68.0 (1208) | 16.9 | <0.001 | 0.49 |
| Chronic ischemic heart disease | 59.4 (963) | 18.8 | 63.7 (2220) | 17.8 | <0.001 | 0.24 |
| Severe vision reduction | 60.8 (1396) | 18.3 | 63.7 (1786) | 18.0 | <0.001 | 0.12 |
| Diabetes mellitus | 61.0 (992) | 18.0 | 63.1 (2188) | 18.3 | 0.004 | 0.12 |
| Cardiac arrhythmia | 59.0 (1046) | 18.2 | 64.1 (2139) | 18.0 | <0.001 | 0.28 |
| Neuropathies | 57.1 (1114) | 18.2 | 65.2 (2075) | 17.6 | <0.001 | 0.45 |
| Dizziness | 57.1 (1109) | 17.9 | 65.3 (2078) | 17.7 | <0.001 | 0.45 |
| Lower limb varicosis | 61.1 (1148) | 18.4 | 63.2 (2037) | 18.0 | 0.002 | 0.12 |
| Asthma/COPD1 | 58.0 (696) | 18.5 | 63.7 (2491) | 17.9 | <0.001 | 0.31 |
| Purine/pyrimidine metabolism disorders/Gout | 57.7 (536) | 18.1 | 63.4 (2643) | 18.1 | <0.001 | 0.31 |
| Hemorrhoids | 59.9 (727) | 18.4 | 63.2 (2459) | 18.1 | <0.001 | 0.18 |
| Cerebral ischemia/Chronic stroke | 59.3 (444) | 18.4 | 62.9 (2742) | 18.1 | <0.001 | 0.20 |
| Cardiac insufficiency | 55.7 (548) | 18.4 | 63.8 (2632) | 17.8 | <0.001 | 0.45 |
| Atherosclerosis/PAOD2 | 54.6 (347) | 19.9 | 63.4 (2835) | 17.8 | <0.001 | 0.48 |
| Renal insufficiency | 55.1 (307) | 19.1 | 63.2 (2875) | 17.9 | <0.001 | 0.45 |
| Intestinal diverticulosis | 60.8 (435) | 17.7 | 62.7 (2751) | 18.3 | 0.046 | 0.10 |
| Rheumatoid arthritis | 55.0 (410) | 18.8 | 63.5 (2768) | 17.8 | <0.001 | 0.47 |
| Osteoporosis | 57.4 (690) | 18.7 | 63.8 (2496) | 17.8 | <0.001 | 0.35 |
| Chronic cholecystitis/Gallstones | 59.1 (271) | 18.4 | 62.7 (2917) | 18.2 | 0.002 | 0.20 |
| Anemia | 55.2 (169) | 18.1 | 62.8 (3017) | 18.1 | <0.001 | 0.42 |
| Migraine | 58.8 (166) | 18.6 | 62.6 (3022) | 18.2 | 0.008 | 0.21 |
| Parkinson’s disease | 49.5 (67) | 18.4 | 62.7 (3121) | 18.1 | <0.001 | 0.73 |
| Lipid metabolism disorders | 61.8 (1460) | 17.9 | 62.9 (1721) | 18.4 | 0.10 | 0.06 |
| Thyroid dysfunction | 61.7 (991) | 18.2 | 62.7 (2196) | 18.2 | 0.15 | 0.05 |
| Prostate hyperplasia | 63.3 (510) | 17.7 | 63.8 (779) | 18.8 | 0.63 | 0.03 |
| Non-inflammatory gynecological problems | 60.8 (245) | 19.7 | 61.7 (1631) | 17.8 | 0.45 | 0.05 |
| Cardiac valve disorders | 61.4 (314) | 18.4 | 62.5 (2872) | 18.2 | 0.31 | 0.06 |
| Kidney stones | 60.7 (124) | 18.5 | 62.5 (3063) | 18.2 | 0.29 | 0.10 |
| Psoriasis | 61.4 (213) | 19.2 | 62.5 (2976) | 18.1 | 0.39 | 0.06 |
| Malignant tumors | 60.9 (332) | 18.0 | 62.6 (2850) | 18.2 | 0.11 | 0.09 |
| | | |||||
| | 63.6 (1298) | 18.4 | 61.6 (1891) | 18.0 | 0.003 | 0.11 |
| | | |||||
| | 63.3 (1863) | 18.2 | 61.2 (1326) | 18.2 | 0.001 | 0.12 |
| | | | | |||
| | 63.0 (2061) | 18.2 | 61.3 (1128) | 18.2 | 0.011 | 0.09 |
| | | |||||
| | 67.1 (347) | 18.7 | 61.8 (2842) | 18.1 | <0.001 | 0.29 |
| | | |||||
| 61.5 (237) | 18.4 | 62.5 (2948) | 18.2 | 0.42 | 0.05 | |
Note: By t-test differences in SRH between different groups were tested for significance; confidence interval: 99%; only significant results are shown in the table.
Marital status: not married includes: single, divorced, widowed; household type: living with others includes: with partner, family members and in an institution; 1: chronic obstructive pulmonary disease; 2: peripheral arterial occlusive disease.
Correlation (Pearson correlation coefficient (r)) of patient characteristics with self-rated health
| | | | |
| Age | −0.08 ** | −0.13 *** | −0.11 *** |
| Income | 0.12 *** | 0.13 *** | 0.13 *** |
| | | | |
| Body mass index (BMI) | −0.13 *** | −0.16 *** | −0.15 *** |
| Alcohol habit score (AUDIT-C) | 0.10 ** | 0.13 *** | 0.12 *** |
| Physical activity (IPAQ-7) | 0.26 *** | 0.22 *** | 0.24 *** |
| | | | |
| Self-efficacy (SWE) | 0.24 *** | 0.20 *** | 0.22 *** |
| Social support (F-SOZU) | 0.15 *** | 0.20 *** | 0.18 *** |
| Depression (GDS) | −0.42 *** | −0.40 *** | −0.41 *** |
| Somatization (4DBL) | −0.42 *** | −0.43 *** | −0.43 *** |
| Anxiety (4DBL) | −0.26 *** | −0.22 *** | −0.23 *** |
| Depression (4DBL) | −0.27 *** | −0.30 *** | −0.29 *** |
| Distress (4DBL) | −0.36 *** | −0.37 *** | −0.37 *** |
| | | | |
| Basic activities of daily living (Barthel) | 0.29 *** | 0.23 *** | 0.25 *** |
| Instrumental activities (IADL) | 0.29 *** | 0.27 *** | -- 1 |
| Characteristic pain intensity (GCPS) | −0.39 *** | −0.42 *** | −0.41 *** |
| Pain Disability score (GCPS) | −0.43 *** | −0.47 *** | −0.46 *** |
Note: *** P values are <0.001; ** P values are <0.01; 1 correlation for the whole sample not shown because of different numbers of items for men and women, respectively.
Correlates of self-rated health in the whole sample: results of a stepwise linear multiple regression model
| Disability score (GCPS) | −0.11 (−0.15/-0.08) | −0.18 | <0.001 |
| Depression (GDS) | −0.96 (−1.31/-0.60) | −0.14 | <0.001 |
| Somatization (4DBL) | −0.61 (−0.79/-0.43) | −0.17 | <0.001 |
| Physical activity (IPAQ-7) (in 1000 MET minutes/week) | 1.00 (0.38/0.97) | 0.09 | <0.001 |
| Instrumental activities (IADL) | 1.11 (0.70/1.51) | 0.11 | <0.001 |
| Characteristic pain intensity (GCPS) | −0.07 (−0.11/-0.03) | −0.09 | <0.001 |
| Monthly income (in 1000 Euro) | 2.00 (0.56/2.51) | 0.06 | <0.001 |
| BMI | −0.24 (−0.38/-0.09) | −0.06 | <0.001 |
| Age | −0.18 (−0.32/-0.05) | −0.05 | 0.001 |
| Self-efficacy (SWE) | 1.60 (0.27/2.94) | 0.05 | 0.002 |
| Parkinson’s disease | −5.72 (−10.63/-0.80) | −0.04 | 0.003 |
| Neuropathies | −1.58 (−3.12/-0.04) | −0.04 | 0.008 |
| Distress (4DBL) | −0.19 (−0.37/0.00) | −0.05 | 0.010 |
Note: R2= .35; variables are listed in order of inclusion in the model.
Factors associated with SRH in males and females respectively
| | | | | | ||
|---|---|---|---|---|---|---|
| Somatization (4DBL) | −0.79 (−1.00/-0.59) | −0.20 | <0.001 | −0.54 (−0.72/-0.37) | −0.16 | <0.001 |
| Disability score (GCPS) | −0.14 (−0.18/-0.11) | −0.21 | <0.001 | −0.10 (−0.14/-0.07) | −0.17 | <0.001 |
| Depression (GDS) | −1.51 (−1.90/-1.12) | −0.20 | <0.001 | −0.91 (−1.24/-0.58) | −0.13 | <0.001 |
| Physical activity (in 1000 MET minutes/week) (IPAQ-7) | 1.00 (0.53/1.14) | 0.13 | <0.001 | 1.00 (0.28/0.94) | 0.07 | <0.001 |
| Activities of daily living (Barthel) | 0.30 (0.16/0.44) | 0.10 | <0.001 | n.s. | | |
| Low or intermediate education | −4.43 (−6.57/-2.29) | −0.09 | <0.001 | n.s. | | |
| Cardiac arrhythmia | −2.57 (−4.34/-0.80) | −0.07 | 0.004 | n.s. | | |
| Characteristic pain intensity (GCPS) | n.s. | | | −0.07 (−0.11/-0.03) | −0.10 | <0.001 |
| Instrumental activities (IADL) | n.s. | | | 1.09 (0.42/1.75) | 0.07 | 0.001 |
| BMI | n.s. | | | −0.24 (−0.37/-0.11) | −0.07 | <0.001 |
| Distress (4DBL) | n.s. | | | −0.30 (−0.47/-0.14) | −0.09 | <0.001 |
| Age | n.s. | | | −0.24 (−0.38/-0.11) | −0.07 | 0.001 |
| Chronic low back pain | n.s. | | | −2.36(−3.97/-0.74) | −0.06 | 0.004 |
| Monthly income (in 1000 Euro) | n.s. | 2.00 (0.39/0.27) | −0.05 | .009 |
Note: all variables that have shown significant results in the bivariate analyses were put in the model; males: R2 = 0.34;
females: R2 = 0.35.